Genetic variants in GTF2H1 and risk of lung cancer: A case-control analysis in a Chinese population

被引:9
|
作者
Wu, Wenting [1 ,2 ]
Liu, Hongliang [1 ,2 ]
Lei, Rong [4 ,5 ]
Chen, Dan [1 ,2 ]
Zhang, Shuyu [1 ,2 ]
Lv, Juan [1 ,2 ]
Wang, Yi [1 ,2 ]
Fan, Weiwei [1 ,2 ]
Qian, Ji [1 ,2 ]
Jin, Guangfu [3 ]
Ma, Hongxia [3 ]
Miao, Ruifen [3 ]
Hu, Zhibin [3 ]
Wang, Haifeng [4 ,5 ]
Jin, Li [1 ,2 ,4 ,5 ]
Wei, Qingyi [6 ]
Shen, Hongbing [3 ]
Huang, Wei [4 ,5 ]
Lu, Daru [1 ,2 ]
机构
[1] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China
[2] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China
[3] Nanjing Med Univ, Canc Res Ctr, Dept Epidemiol & Biostat, Nanjing 210029, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200025, Peoples R China
[5] Chinese Natl Human Genome Ctr, Shanghai 200025, Peoples R China
[6] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA
关键词
GTF2H1; gene; Single nucleotide polymorphism; Haplotype; Lung cancer; Case-control study; Susceptibility; NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTOR-IIH; DNA-DAMAGE; TFIIH; ACTIVATION; XPG; POLYMORPHISM; SMOKING; DOMAIN; HAPLOTYPES;
D O I
10.1016/j.lungcan.2008.05.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
GTF2H1, the p62 subunit of the multiprotein complex transcription factor IIH (TFIIH), participates in both the nucleotide excision repair process and transcription control by specifically interacting with a variety of factors important in carcinogenesis. To elucidate the role of genetic variation in GTF2H1 in the etiology of lung cancer, we conducted a case-control study of 500 incident lung cancer cases and 517 controls in a Chinese population by genotyping six common single nucleotide polymorphisms (SNPs) in GTF2H1. An increased risk was associated with the variant genotypes of rs3802967 [adjusted odds ratio (OR)=1.38.95% confidence interval (CI)=1.04-1.82], rs4150606 (adjusted OR=1.44, 95% CI=1.08-1.92), and rs4150678 (adjusted OR=1.37, 95% CI=1.04-1.81) in a dominant genetic model. The risk for rs3802967 C/T+T/T genotypes was more pronounced among males subjects (P=0.002). In contrast, a decreased risk was associated with the rs4150667 T/T genotype (adjusted OR=0.59, 95% CI=0.38-0.93) in a recessive model. Haplotype analysis showed that the haplotype "222212" (1 for common alleles and 2 for minor alleles) was associated with increased risk of lung cancer (P=0.03). Further evaluation using luciferase reporter constructs showed that the T allele of rs3802967 had higher luciferase expression, suggesting that the -79C -> T change may affect transcriptional activation of GTF2H1. Taken together, these results suggest that GTF2H1 polymorphisms/haplotypes may contribute to genetic susceptibility to lung cancer. (C) 2008 Published by Elsevier Ireland Ltd.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [41] The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population
    Jun Tang
    Jianzhu Zhao
    Jungang Zhao
    Medical Oncology, 2014, 31
  • [42] The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population
    Tang, Jun
    Zhao, Jianzhu
    Zhao, Jungang
    MEDICAL ONCOLOGY, 2014, 31 (09) : 1 - 7
  • [43] Genetic analysis of ADIPOQ variants and gastric cancer risk: a hospital-based case-control study in China
    Ye, Lei
    Zhang, Zuo-Yang
    Du, Wei-Dong
    Schneider, Marion E.
    Qiu, Yue
    Zhou, Yuan
    Zhou, Fu-Sheng
    Zuo, Xian-Bo
    Chen, Gang
    Ma, Xue-Ling
    Xia, Hong-Zhen
    Xu, Song
    Wu, Ji-Feng
    Xu, Hong-Yuan
    Zhang, Xue-Jun
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [44] Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study
    Zhao, Peng
    Zhao, Lin
    Zou, Peng
    Lu, Ailin
    Liu, Ning
    Yan, Wei
    Kang, Chunsheng
    Fu, Zhen
    You, Yongping
    Jiang, Tao
    BMC CANCER, 2012, 12
  • [45] Association of XPC Gene Polymorphisms with Colorectal Cancer Risk in a Southern Chinese Population: A Case-Control Study and Meta-Analysis
    Hua, Rui-Xi
    Zhu, Jinhong
    Jiang, Dan-Hua
    Zhang, Shao-Dan
    Zhang, Jiang-Bo
    Xue, Wen-Qiong
    Li, Xi-Zhao
    Zhang, Pei-Fen
    He, Jing
    Jia, Wei-Hua
    GENES, 2016, 7 (10)
  • [46] Sequence variations in DNA repair gene XPCis associated with lung cancer risk in a Chinese population: a case-control study
    Yun Bai
    Liang Xu
    Xiaobo Yang
    Zhibin Hu
    Jing Yuan
    Feng Wang
    Minhua Shao
    Wentao Yuan
    Ji Qian
    Hongxia Ma
    Ying Wang
    Hongliang Liu
    Weihong Chen
    Lin Yang
    Guangfu Jing
    Xiang Huo
    Feng Chen
    Yanhong Liu
    Li Jin
    Qingyi Wei
    Wei Huang
    Hongbing Shen
    Daru Lu
    Tangchun Wu
    BMC Cancer, 7
  • [47] Risk factors shared by COPD and lung cancer and mediation effect of COPD: two center case-control studies
    Yang, Lei
    Lu, Xiaoxiao
    Deng, Jieqiong
    Zhou, Yumin
    Huang, Dongsheng
    Qiu, Fuman
    Yang, Xiaorong
    Yang, Rongrong
    Fang, Wenxiang
    Ran, Pixin
    Zhong, Nanshan
    Zhou, Yifeng
    Fang, Shenying
    Lu, Jiachun
    CANCER CAUSES & CONTROL, 2015, 26 (01) : 11 - 24
  • [48] Role of cigarette filter on the risk of oral cancer: a case-control study in a Chinese population
    Fu, J. Y.
    Gao, J.
    Zhang, Z. Y.
    Zheng, J. W.
    Zhong, L. P.
    Luo, J. F.
    Xiang, Y. B.
    ORAL DISEASES, 2013, 19 (01) : 80 - 84
  • [49] Genetic variants of m1A modification genes and the risk of neuroblastoma: novel insights from a Chinese case-control study
    Jiaming Chang
    Lei Lin
    Wenli Zhang
    Jiliang Yang
    Mengzhen Zhang
    Huimin Yin
    Xinxin Zhang
    Chunlei Zhou
    Yan Zou
    Jing He
    Human Genomics, 19 (1)
  • [50] Association between smoking and environmental tobacco smoke with lung cancer risk: a case-control study in the Fujian Chinese population
    Zhuang, Jinman
    Liu, Zhi Qiang
    Xiao, Rendong
    Xu, Qiu Ping
    Xiong, Wei Min
    Li, Xu
    Cai, Lin
    He, Fei
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2022, 30 (08): : 2047 - 2057